Acceleron Signs Deals for Bone-Forming Compounds

By Business Review Editor

Pharma Deals Review: Vol 2008 Issue 93 (Table of Contents)

Published: 8 Mar-2008

DOI: 10.3833/pdr.v2008.i93.205     ISSN: 1756-7874

Section: Research & Development



Acceleron Pharma entered into research and development agreement with Celgene for Acceleron’s ACE-011 that is in phase 1 clinical trials for treating cancer-related bone loss due to multiple myeloma, bone metastases of solid tumors or cancer treatments...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details